These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 21507187

  • 1. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer.
    Davison BJ, Goldenberg SL.
    BJU Int; 2011 Dec; 108(11):1787-93. PubMed ID: 21507187
    [Abstract] [Full Text] [Related]

  • 2. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance.
    Davison BJ, Breckon E.
    Patient Educ Couns; 2012 Jun; 87(3):369-74. PubMed ID: 22177658
    [Abstract] [Full Text] [Related]

  • 3. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
    Davison BJ, Oliffe JL, Pickles T, Mroz L.
    Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
    [Abstract] [Full Text] [Related]

  • 4. Information and decision-making preferences of men with prostate cancer.
    Davison BJ, Degner LF, Morgan TR.
    Oncol Nurs Forum; 1995 Oct; 22(9):1401-8. PubMed ID: 8539181
    [Abstract] [Full Text] [Related]

  • 5. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
    van Vugt HA, Roobol MJ, van der Poel HG, van Muilekom EH, Busstra M, Kil P, Oomens EH, Leliveld A, Bangma CH, Korfage I, Steyerberg EW.
    BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
    [Abstract] [Full Text] [Related]

  • 6. Provision of individualized information to men and their partners to facilitate treatment decision making in prostate cancer.
    Davison BJ, Goldenberg SL, Gleave ME, Degner LF.
    Oncol Nurs Forum; 2003 Jul; 30(1):107-14. PubMed ID: 12515988
    [Abstract] [Full Text] [Related]

  • 7. Impact of health information-seeking behavior and personal factors on preferred role in treatment decision making in men with newly diagnosed prostate cancer.
    Davison BJ, Breckon EN.
    Cancer Nurs; 2012 Jul; 35(6):411-8. PubMed ID: 22067700
    [Abstract] [Full Text] [Related]

  • 8. Evidence-based patient choice: a prostate cancer decision aid in plain language.
    Holmes-Rovner M, Stableford S, Fagerlin A, Wei JT, Dunn RL, Ohene-Frempong J, Kelly-Blake K, Rovner DR.
    BMC Med Inform Decis Mak; 2005 Jun 20; 5():16. PubMed ID: 15963238
    [Abstract] [Full Text] [Related]

  • 9. Current decision-making in prostate cancer therapy.
    Cox J, Amling CL.
    Curr Opin Urol; 2008 May 20; 18(3):275-8. PubMed ID: 18382237
    [Abstract] [Full Text] [Related]

  • 10. PCA: prostate cancer, patient-centred approach or both?
    Denis L, Joniau S, Bossi A, Baskin-Bey E, Fitzpatrick JM.
    BJU Int; 2012 Jul 20; 110(1):16-22. PubMed ID: 22233268
    [Abstract] [Full Text] [Related]

  • 11. Measurement of factors influencing the participation of patients with prostate cancer in clinical trials: a Canadian perspective.
    Davison BJ, So A, Goldenberg SL, Berkowitz J, Gleave ME.
    BJU Int; 2008 Apr 20; 101(8):982-7. PubMed ID: 18005198
    [Abstract] [Full Text] [Related]

  • 12. Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance.
    Pickles T, Ruether JD, Weir L, Carlson L, Jakulj F, SCRN Communication Team.
    BJU Int; 2007 Sep 20; 100(3):544-51. PubMed ID: 17532857
    [Abstract] [Full Text] [Related]

  • 13. Communicating effectively with the patient and family about treatment options for prostate cancer.
    Kunkel EJ, Myers RE, Lartey PL, Oyesanmi O.
    Semin Urol Oncol; 2000 Aug 20; 18(3):233-40. PubMed ID: 10975496
    [Abstract] [Full Text] [Related]

  • 14. Men considering a hypothetical treatment for prostate cancer: a comparison to patients.
    Van Manen L, Feldman-Stewart D, Brundage MD.
    Patient Educ Couns; 2006 Apr 20; 61(1):33-42. PubMed ID: 16257170
    [Abstract] [Full Text] [Related]

  • 15. Factors that predict treatment choice and satisfaction with the decision in men with localized prostate cancer.
    Berry DL, Ellis WJ, Russell KJ, Blasko JC, Bush N, Blumenstein B, Lange PH.
    Clin Genitourin Cancer; 2006 Dec 20; 5(3):219-26. PubMed ID: 17239276
    [Abstract] [Full Text] [Related]

  • 16. 'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option.
    O'Callaghan C, Dryden T, Hyatt A, Brooker J, Burney S, Wootten AC, White A, Frydenberg M, Murphy D, Williams S, Schofield P.
    Psychooncology; 2014 Dec 20; 23(12):1391-8. PubMed ID: 24830805
    [Abstract] [Full Text] [Related]

  • 17. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer.
    Steginga SK, Occhipinti S, Gardiner RA, Yaxley J, Heathcote P.
    Urology; 2004 Apr 20; 63(4):751-6. PubMed ID: 15072894
    [Abstract] [Full Text] [Related]

  • 18. Comparing a generic and individualized information decision support intervention for men newly diagnosed with localized prostate cancer.
    Davison BJ, Goldenberg SL, Wiens KP, Gleave ME.
    Cancer Nurs; 2007 Apr 20; 30(5):E7-15. PubMed ID: 17876177
    [Abstract] [Full Text] [Related]

  • 19. Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote.
    Denberg TD, Melhado TV, Steiner JF.
    Cancer; 2006 Aug 01; 107(3):620-30. PubMed ID: 16802287
    [Abstract] [Full Text] [Related]

  • 20. Prostate cancer screening and informed decision-making: provider and patient perspectives.
    Bowen DJ, Hannon PA, Harris JR, Martin DP.
    Prostate Cancer Prostatic Dis; 2011 Jun 01; 14(2):155-61. PubMed ID: 21243007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.